Importantly, previous studies have shown that individuals harboring either DNMT3A or TET2 CHIP-driver mutations in circulating blood cells experience increased mortality in the presence of heart failure or aortic valve stenosis8–12. The gene discussed is DNMT3A; the disease is heart failure.